EMAGIX Inc. is an early-stage research-driven biomedical company who has developed an algorithm-driven approach for diagnosis of retinal and brain vascular injury. Our vision is to translate our technology, expertise and analytical power, into cutting-edge clinical decision support systems and to provide personalized, tailored and predictive diagnostic tools.

Contact

Dr. Alon Friedman
Founder & CEO
alon.friedman@emagix.ca

Related News

Posts